Supplement Risk Limits Set “Substantially” Below Drugs By DSHEA, FDA Told
This article was originally published in The Tan Sheet
Executive Summary
In the context of the Dietary Supplement Health & Education Act, the type of risk from dietary supplements that should be considered "significant or unreasonable" may be "substantially less serious than the types of risk that would be considered significant or unreasonable for drugs," according to April 4 congressional comments to FDA